Quality improvement needed in quality improvement randomised trials: systematic review of interventions to improve care in diabetes — Noah Ivers (2013) | RDL Network
Quality improvement needed in quality improvement randomised trials: systematic review of interventions to improve care in diabetes
Article 2013 en
Authors
NI
Noah Ivers
AT
Andrea C. Tricco
MT
Monica Taljaard
Abstract
1 min read
Nearly half of the included QI trials in this review were judged to have high risk of bias. Such trials have serious limitations that put the findings in question and therefore inhibit evidence-based QI. There is a need to limit the potential for bias when conducting QI trials and improve the quality of reporting of QI trials so that stakeholders have adequate evidence for implementation.
Kristin J. Konnyu, Sharlini Yogasingam, Johanie Lépine, Katrina Sullivan, Mostafa Alabousi, Alun Edwards, Michael Hillmer, Sathya Karunananthan, John N. Lavis, Stefanie Linklater, Braden Manns, David Moher, Sameh Mortazhejri, Samir Nazarali, P. Alison Paprica, Tim Ramsay, Paul M. Ryan, Peter Sargious, Kaveh G Shojania, Sharon E. Straus, Marcello Tonelli, Andrea C. Tricco, Brigitte Vachon,
Nadera Ahmadzai, Shaun Kilty, Wei Cheng, Leila Esmaeilisaraji, Dianna Wolfe, James P. Bonaparte, David Schramm, Elizabeth M. Fitzpatrick, Vincent Lin, Becky Skidmore, David Moher, Brian Hutton
Lucas Lauder, Bruno R. da Costa, Sebastian Ewen, S. Scholz, William Wijns, Thomas F. Lüscher, Patrick W. Serruys, Elazer R. Edelman, Davide Capodanno, Michael Böhm, Peter Jüni, Felix Mahfoud
Discussion(0)
No comments yet. Be the first to comment.